Biosimilars provide new growth options

One ongoing concern for people and governments in Asia is the rising cost of healthcare. Every year, governments spend more on caring for their population while the people themselves worry that treatments and drugs could prove to be too expensive.

Since the 1990s, one way to lower costs has been to use generic drugs, which have made some of the most sought-after and expensive medicines in the world much cheaper.

But doing the same with the more complex biologic drugs that are often seen as the future of medicine may not be so easy.